Clinical importance of aspirin and clopidogrel resistance

doi:10.4330/wjc.v2.i7.171

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 2, Issue 7

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7929)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-4) series, Tables (1-4) series.

Item

Count

PDF

654

HTML

6411

Figures (1-4)

617

Tables (1-4)

247

Sum=7929

Jul 26, 2010 (publication date) through Feb 3, 2025

Times Cited of This Article

Times Cited (46)

Journal Information of This Article

Publication Name

World Journal of Cardiology

ISSN

1949-8462

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Cardiol. Jul 26, 2010; 2(7): 171-186
Published online Jul 26, 2010. doi: 10.4330/wjc.v2.i7.171

Full Size Figure Download Figure

Figure 1 Pathways of platelet activation and mechanism of action of antiplatelet agents[2]. COX: Cyclooxygenase; GP: Glycoprotein; TxA₂: Thromboxane A₂; ASA: Acetylsalicylic acid; NSAIDs: Nonsteroidal anti-inflammatory drugs; PAF: Platelet-activating factor.

Citation: Feher G, Feher A, Pusch G, Koltai K, Tibold A, Gasztonyi B, Papp E, Szapary L, Kesmarky G, Toth K. Clinical importance of aspirin and clopidogrel resistance. World J Cardiol 2010; 2(7): 171-186
URL: https://www.wjgnet.com/1949-8462/full/v2/i7/171.htm
DOI: https://dx.doi.org/10.4330/wjc.v2.i7.171